What is a common method used in drug discovery?

• A. High-throughput screening.
• B. Long-term epidemiological studies.
• C. Post-marketing surveillance.
• D. Traditional knowledge review.

Answer: (A)

The main idea is how researchers identify potential new drug candidates by testing many compounds quickly against a biological target. High-throughput screening uses automation and miniaturized assays to evaluate hundreds of thousands to millions of compounds in a short time, producing data that reveal which ones show the desired activity and deserve further optimization. This rapid, large-scale approach is central to modern drug discovery because it efficiently generates a pool of “hits” that can be refined into lead compounds with the right potency, selectivity, and drug-like properties.

Long-term epidemiological studies, by contrast, examine disease patterns and risk factors in populations and are valuable for understanding disease etiology, treatment effectiveness in real-world contexts, or public health trends—not for identifying new chemical entities or initiating drug development. Post-marketing surveillance monitors safety and adverse events after a drug is approved, which is essential for pharmacovigilance but occurs after discovery and development. Traditional knowledge review can inspire ideas or identify natural products with medicinal potential, but it is not the primary, scalable method used to screen vast chemical libraries in contemporary drug discovery.